Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001493152-25-019890
Filing Date
2025-10-28
Accepted
2025-10-28 16:25:07
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A formdefa14a.htm DEFA14A 28761
2 GRAPHIC proxy_001.jpg GRAPHIC 441794
3 GRAPHIC proxy_002.jpg GRAPHIC 399034
  Complete submission text file 0001493152-25-019890.txt   1188098
Mailing Address 433 PLAZA REAL SUITE 275 BOCA RATON FL 33432
Business Address 433 PLAZA REAL SUITE 275 BOCA RATON FL 33432 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

EIN.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39717 | Film No.: 251425160
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)